The Claim
Creatine supplementation at human-equivalent doses increases metastatic dissemination and reduces survival in mouse models of cancer.
What the research says
Challenges is higher
Challenge is ahead, but a single strong supporting study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In mice with cancer, giving them creatine at doses similar to what humans take causes more cancer spread (metastasis) and shorter survival times.
See the scientific wording
Creatine supplementation at human-equivalent doses increases metastatic dissemination and reduces survival in mouse models of cancer.
Creatine taken as a supplement enters megakaryocytes, the cells that make platelets. Inside these cells, creatine increases the production of creatine kinase B, which modifies a protein called STAT5B. This modification turns on genes that make platelets hyperactive. Hyperactive platelets stick to cancer cells in the blood, helping them escape blood vessels and form new tumors in distant organs, leading to increased metastasis.
What the research says
3 studiesStudy: Creatine uptake promotes dendritic cell activation and enhances antitumor immunity
The study shows that giving creatine to mice with cancer actually helps their immune system fight the cancer and makes tumors grow slower, which is the opposite of what the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 3 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.